Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Shakhawat Chowdhury, Imran Rahman Chowdhury & Md. Hasan Zahir. (2018) Trihalomethanes in desalinated water: Human exposure and risk analysis. Human and Ecological Risk Assessment: An International Journal 24:1, pages 26-48.
Read now
Read now
Alan R. Schned, Angeline S. Andrew, Carmen J. Marsit, Karl T. Kelsey, Michael S. Zens & Margaret R. Karagas. (2008) Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States. Scandinavian Journal of Urology and Nephrology 42:3, pages 237-242.
Read now
Read now
Lars Fokdal, Morten Høyer & Hans von der Maase. (2006) Radical radiotherapy for urinary bladder cancer: treatment outcomes. Expert Review of Anticancer Therapy 6:2, pages 269-279.
Read now
Read now
Sophie D. Fosså & Eva Skovlund. (2002) Selection of Patients may Limit the Generalizability of Results from Cancer Trials. Acta Oncologica 41:2, pages 131-137.
Read now
Read now
Sten Holmäng, Hans Hedelin, Claes Anderström, Erik Holmberg & Sonny L. Johansson. (2000) Prospective Registration of all Patients in a Geographical Region with Newly Diagnosed Bladder Carcinomas during a Two-year Period. Scandinavian Journal of Urology and Nephrology 34:2, pages 95-101.
Read now
Read now
H. Wijkström, S.M. Cohen, R.A. Gardiner, T. Kakizoe, M. Schoenberg, G. Steineck & K. Tobisu. (2000) Prevention and Treatment of Urothelial Premalignant and Malignant Lesions. Scandinavian Journal of Urology and Nephrology 34:205, pages 116-135.
Read now
Read now
Sophie D. Fosså, Nina Aass, Sigurd Ous, Hakon Wéhre, Kari Ilner & Einar Hannisdal. (1996) Survival After Curative Treatment of Muscle-Invasive Bladder Cancer. Acta Oncologica 35:sup8, pages 59-65.
Read now
Read now
Articles from other publishers (12)
Shakhawat Chowdhury, Imran Rahman Chowdhury, Mohammad Abu Jafar Mazumder & Mohammad Saleh Al-Suwaiyan. (2020) Predicting risk and loss of disability-adjusted life years (DALY) from selected disinfection byproducts in multiple water supply sources in Saudi Arabia. Science of The Total Environment 737, pages 140296.
Crossref
Crossref
Shenling Pan, Wei An, Hongyan Li, Ming Su, Jinliang Zhang & Min Yang. (2014) Cancer risk assessment on trihalomethanes and haloacetic acids in drinking water of China using disability-adjusted life years. Journal of Hazardous Materials 280, pages 288-294.
Crossref
Crossref
Isabelle Soerjomataram, Joannie Lortet-Tieulent, Jacques Ferlay, David Forman, Colin Mathers, D Maxwell Parkin & Freddie Bray. (2012) Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer. BMC Medical Research Methodology 12:1.
Crossref
Crossref
George R. Prout, Margaret N. Wesley, Rosemary Yancik, Lynn A. G. Ries, Richard J. Havlik & Brenda K. Edwards. (2005) Age and comorbidity impact surgical therapy in older bladder carcinoma patients. Cancer 104:8, pages 1638-1647.
Crossref
Crossref
George R. ProutJr.Jr., Margaret N. Wesley, Peter G. McCarron, Vivien W. Chen, Raymond S. Greenberg, Robert M. Mayberry & Brenda K. Edwards. (2004) Survival experience of black patients and white patients with bladder carcinoma. Cancer 100:3, pages 621-630.
Crossref
Crossref
Zhujun Zhang, Toshiro Shirakawa, Nobuyuki Hinata, Akira Matsumoto, Masato Fujisawa, Hiroshi Okada, Sadao Kamidono, Masafumi Matsuo & Akinobu Gotoh. (2003) Combination with CD/5-FC gene therapy enhances killing of human bladder-cancer cells by radiation. The Journal of Gene Medicine 5:10, pages 860-867.
Crossref
Crossref
M.M Knap, F Lundbeck & J Overgaard. (2003) The role of pelvic lymph node dissection as a predictive and prognostic factor in bladder cancer. European Journal of Cancer 39:5, pages 604-613.
Crossref
Crossref
Lisa Sengeløv & Hans von der Maase. (1999) Radiotherapy in bladder cancer. Radiotherapy and Oncology 52:1, pages 1-14.
Crossref
Crossref
Sten Holmang, Hans Hedelin, Claes Anderstrom & Sonny L. Johansson. (1997) Long-Term Followup of all Patients with Muscle Invasive (Stages T2, T3 and T4) Bladder Carcinoma in a Geographical Region. The Journal of Urology, pages 389-392.
Crossref
Crossref
Sten HolmangHans HedelinClaes AnderstromSonny L. Johansson. (1997) Long-Term Followup of all Patients with Muscle Invasive (Stages T2, T3 and T4) Bladder Carcinoma in a Geographical Region. Journal of Urology 158:2, pages 389-392.
Crossref
Crossref
Lisa Sengeløv, Søren Klintorp, Hanne Havsteen, Claus Kamby, Susanne L. Hansen & Hans von der Maase. (1997) Treatment outcome following radiotherapy in elderly patients with bladder cancer. Radiotherapy and Oncology 44:1, pages 53-58.
Crossref
Crossref
Haakon Wæhre, Sigurd Ous, Bjørn Klevmark, Bernt Kvarstein, Thomas Urnes, Per Øgreid, Truls E. Bjerklund Johansen & Sophie D. Fosså. (1993) A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer. Cancer 72:10, pages 3044-3051.
Crossref
Crossref